Dicot
  • The Pharmaceutical Project
    • Sexual dysfunctions
    • The Market
    • The drug candidate LIB-01
    • Patent
    • Publications
    • Advisory expert group
  • About Dicot
    • Business idea, strategy & vision
    • Management
    • Board
    • Background
    • Contact
  • News
  • Investor relations
    • The share
    • The market
    • Strategy and business model
    • Corporate governance
    • Reports and issues
    • Analysis
  • Subscribe
  • Select language
    • ENG
    • SVE
  • Home /
  • Investor relations /
  • Reports and issues

Financial reports and issues

  • Financial calendar
  • Financial reports
  • Previous issues

Subscribe



Dicot Logo

Dicot is developing a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs.

DICOT AB
Kungsgatan 16
SE-753 32 Uppsala
SWEDEN
+46 (0) 70-663 60 09
info@dicot.se

Subscribe

Our website uses cookies to improve your experience.
By continued usage of this site you approve of our use of cookies. Read more about cookies on dicot.se